NASDAQ:IOSP Innospec Q1 2025 Earnings Report $96.72 -1.16 (-1.19%) Closing price 09/29/2026 04:00 PM EasternExtended Trading$96.75 +0.03 (+0.03%) As of 08:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Innospec EPS ResultsActual EPS$1.42Consensus EPS $1.40Beat/MissBeat by +$0.02One Year Ago EPS$1.75Innospec Revenue ResultsActual Revenue$440.80 millionExpected Revenue$466.50 millionBeat/MissMissed by -$25.70 millionYoY Revenue Growth-11.90%Innospec Announcement DetailsQuarterQ1 2025Date5/8/2025TimeAfter Market ClosesConference Call DateFriday, May 9, 2025Conference Call Time9:00AM ETUpcoming EarningsInnospec's Q3 2026 earnings is estimated for Tuesday, November 3, 2026, based on past reporting schedules, with a conference call scheduled on Wednesday, November 4, 2026 at 10:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesConference Call AudioConference Call TranscriptSlide DeckPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Innospec Q1 2025 Earnings Call TranscriptProvided by QuartrMay 9, 2025ShareShareShare This ReportLink copied to clipboard.Key Takeaways Innospec delivered first quarter results in line with expectations as strong growth in Fuel Specialties offset softer Performance Chemicals and Oilfield Services. Fuel Specialties saw double-digit operating income growth and margin expansion, reinforcing its role as a high-margin, cash-generative business. Performance Chemicals revenue rose 5% on volume and price mix gains but operating income fell 6% and gross margins contracted by 2.4 points due to a weaker sales mix, pricing pressure, and inventory caution amid tariff uncertainty. Oilfield Services revenue plunged 37% and operating income dropped 76% year-on-year after losing Latin America sales, prompting US cost-structure realignment and planned DRA capacity expansion for sequential improvement. The company ended Q1 with a net cash position of $300 million, zero debt, a 10% dividend increase to $0.84 per share, and up to $50 million remaining under its share buyback authorization. AI Generated. May Contain Errors.Conference Call Audio Live Call not available Earnings Conference CallInnospec Q1 202500:00 / 00:00Speed:1x1.25x1.5x2xTranscript SectionsPresentationParticipantsPresentationSkip to Participants Operator00:00:00Thank you for standing by. Welcome to Innospec's first quarter 2025 earnings release and conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question-and-answer session. To ask a question during the session, you need to press star one one* on your telephone keypad. You will then hear an automatic message advising your hand is raised. To withdraw a question, please press star one one* again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead. David JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate Secretary at Innospec00:00:37Thank you. Welcome to Innospec's first quarter earnings call. The earnings release for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risk and uncertainties that could cause actual results to differ materially from anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's 10-K, 10-Qs, and other filings with the SEC. Please see the SEC site and Innospec site for these and related documents. In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for or superior to those prepared in accordance with GAAP. David JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate Secretary at Innospec00:01:29They are included as additional items to aid investor understanding of the company's performance in addition to the impact that these items and events had on financial results. With me today from Innospec are Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer. With that, turn it over to you, Patrick. Patrick WilliamsPresident and CEO at Innospec00:01:47Thank you, David, and welcome everyone to Innospec's first quarter 2025 conference call. This was a good quarter for Innospec with overall results in line with our expectations. Against an increasingly volatile economic backdrop, our balanced portfolio benefited from strong growth in Fuel Specialties, which offset lower results in Performance Chemicals and Oilfield Services. Performance Chemicals began the quarter with good momentum, similar to other companies' activity moderated due to April 2 tariff announcements. While the majority of our products go into consumer staples, we believe that customers will remain conservative and manage inventory levels closely in the short term while uncertainty surrounding trade policy remains. While the second quarter has started broadly similar to the first, market conditions are extremely volatile. We currently expect these conditions to be a headwind against our stated 2025 target for sequential improvement in operating income. Patrick WilliamsPresident and CEO at Innospec00:02:50Despite these near-term challenges, our pipeline continues to develop in all end markets, and we do not see any change in our customers' long-term drive towards technologies which deliver superior performance and value. Fuel Specialties had an excellent quarter. Operating income grew by double digits and margins expanded. The team continued to make progress on margin improvement with all regions contributing to the strong performance. While there is significant uncertainty in the current market, global fuel demand has historically been relatively steady through economic cycles. In addition, our Fuel Specialties business has been a consistent high-margin, strong cash generator. Against this backdrop, we remained focused on delivering full-year operating income growth and margin improvement. Oilfield Services' operating income and margins were below our target and expectations. Operating income declined on a sequential basis on lower-than-expected activity. Patrick WilliamsPresident and CEO at Innospec00:03:54As expected, there were no sales in Latin America, and any potential recovery is likely delayed due to the indirect impact of ongoing trade policy negotiations. These declines were partially offset by continued growth and strong performance in our Middle East and our DRA business. We remain on track to bring our previously announced expansion for our market-leading proprietary DRA technology online in the fourth quarter. In addition to our top-line initiatives, we have begun a series of actions to align our U.S. cost structure with the market. We expect these initiatives to drive sequential operating income and margin improvement in the coming quarters and leave us well-positioned for profitable growth. Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. I will return with some concluding comments. After that, Ian and I will take your questions. Ian. Ian CleminsonEVP and CFO at Innospec00:04:53Thanks, Patrick. During slide seven in the presentation, the company's total revenues for the first quarter were $440.8 million, a 12% decrease from $500.2 million a year ago. Overall gross margin decreased by 2.7 percentage points from last year to 28.4%. Adjusted EBITDA for the quarter was $54 million compared to $64 million last year, and net income for the quarter was $32.8 million compared to $41.4 million a year ago. Our GAAP earnings per share were $1.31, including special items, the net effect of which decreased our first quarter earnings by $0.11 per share. A year ago, we reported GAAP earnings per share of $1.65, which included the negative impact from special items of $0.10 per share. Excluding special items in both years, our Adjusted EPS for the quarter was $1.42 compared to $1.75 a year ago. Ian CleminsonEVP and CFO at Innospec00:06:05Turning to slide eight, revenues in Performance Chemicals for the first quarter were $168.4 million, up 5% from last year's $160.8 million. Volume growth of 5% and a positive price mix of 3% were offset by a negative currency impact of 3%. Gross margins of 21% decreased 2.4 percentage points compared to 23.4% in the same quarter in 2024 due to a weaker sales mix and lower sales pricing. Operating income of $19.8 million decreased 6% on $21.1 million last year. Moving on to slide nine, revenues in Fuel Specialties for the first quarter were $170.3 million, down 4% from the $176.9 million reported a year ago, with a 2% adverse price mix and a negative currency impact of 2%. Fuel Specialties' gross margins of 35.7% were 1.4 percentage points above the same quarter last year, benefiting from a stronger sales mix and stable pricing. Ian CleminsonEVP and CFO at Innospec00:07:24Operating income of $36.9 million was up 10% from $33.4 million a year ago. Moving on to slide ten, revenues in Oilfield Services for the quarter were $102.1 million, down 37% from $162.5 million in the first quarter last year, driven mostly by a lack of Latin American business. Gross margins of 28.4% decreased 6.9 percentage points from last year's 35.3% on a weaker sales mix. Operating income of $4.1 million decreased 76% from $16.9 million one year ago. It is now over a year since we made sales to our major Latin American customer. From Q2 onwards, our quarterly results will be directly comparable and not show the sharp decreases we have seen year over year from this one piece of business. Turning to slide eleven, corporate costs for the quarter were $17.7 million compared with $20.2 million a year ago, driven by lower personnel-related costs. Ian CleminsonEVP and CFO at Innospec00:08:37The effective tax rate for the quarter was 26.1% compared to 25.1% a year ago. Moving on to slide twelve, cash from operating activities was $28.3 million before capital expenditures of $15.5 million. For the first quarter, we bought back 34,100 shares at a cost of $3.3 million. As of March 31st, Innospec had $299.8 million in cash and cash equivalents and no debt. I'll turn it back over to Patrick for some final comments. Patrick WilliamsPresident and CEO at Innospec00:09:17Thank you, Ian. With our diversified global supply chain and manufacturing locations, we believe that we are well-positioned to manage the direct impacts of the global tariffs. Despite any near-term volatility, we remain focused on our continued commitment to security of supply, innovation, and world-class customer service. We will continue to implement improvements across all our businesses that will position us for growth and margin expansion as market conditions recover. Our strong debt-free balance sheet allows for significant flexibility in the current environment to pursue further M&A, dividend growth, organic investment, and buybacks. Cash generation was again positive this quarter, and our net cash position increased to almost $300 million after purchasing 34,100 shares at a cost of $3.3 million. In addition, this quarter, our board approved a further 10% increase in our semiannual dividend to $0.84 per share, continuing our record of returning value to shareholders. Patrick WilliamsPresident and CEO at Innospec00:10:25Now I will turn the call over to the operator, and Ian and I will take your questions. Operator00:10:30Thank you, dear participants. As a reminder, if you wish to ask a question, please press star one one on your telephone keypad and wait for your name to be announced. To withdraw a question, please press star one one again. Please then bow or compile the Q&A or study. This will take a few moments. Now we are going to take up our first question. It comes from the line of Mike Harrison from Seaport Research Partners. Your line is open. Please ask your question. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:10:59Hi, good morning. Ian CleminsonEVP and CFO at Innospec00:11:01Morning, Mike. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:11:03Morning, Mike. I was hoping that you could give us maybe a little bit more detail on how you guys are looking at the direct impact of tariffs. Any color that you can provide on what tariffs could mean to your input costs? If you could also give us any detail on portions of your business where you're maybe exporting out of the U.S. and could see some of your products affected by tariffs or bringing product into the U.S., I guess. Ian CleminsonEVP and CFO at Innospec00:11:41Yeah, Mike, I'll let Ian start with that question. I'm sure I have some additional information to add. Patrick WilliamsPresident and CEO at Innospec00:11:48Sure. Mike, like many other companies, we're monitoring the situation. It changes daily, so it's not an easy backdrop to plan against. Our supply chains are really well-positioned to source and manufacture across the different regions. We have various optionality there which we can implement. We're monitoring tariffs, and a lot of that is really an extension of the supply chain and logistics problems that we've seen over the last number of years, including during the pandemic. As more details emerge, we'll position ourselves accordingly. What we're not going to do is make knee-jerk reactions, change manufacturing, change supply chain until we're absolutely certain of the background position. In terms of the general impacts, they're not that high. Our trade with China, both in terms of raw materials and finished products, is pretty low. We do have a lot of trade from Europe into the U.S. Patrick WilliamsPresident and CEO at Innospec00:12:53from the U.S. into Europe. Each of the businesses is slightly differently impacted. We believe that in Performance Chemicals, the main impact will not be economic in terms of the impact of tariffs. It will actually be on the consumer and the customer caution that we have seen in the first quarter. We think that will be the main headwind. That does not change our focus on the R&D and the investment in the technologies that we have. We do not think that changes any direction from our customers. I think in Fuel Specialties, again, that is a business that is regionally based. I think we can handle all the different dynamics there. As we have moved through different economic cycles with that business, it tends to be a fairly stable business. We do not expect there to be any financial impacts or any economic headwinds in that business. Patrick WilliamsPresident and CEO at Innospec00:13:48I think in Oilfield Services, our main concern is with Mexico and the difficult negotiations that are going on there. That's likely to delay any resumption of the Mexican business, which we lost just over a year ago. There are a lot of moving parts across all our business, but most of it we think we can manage. As long as we've got a firm and solid backdrop, we'll deal with what's in front of us. Ian CleminsonEVP and CFO at Innospec00:14:15Yeah, I think Mike and Ian covered it very, very well. I think the key here is that you do not panic in markets like this. It will work itself out. As Ian alluded to, we do not have a lot of imports or exports going from China and/or India. I think that the positive is, too, is we have flexible assets. If and when we need to turn those assets a different direction, we can do that. We are in a strong position there. I think another thing, a little bit of color to that, too, is Ian alluded to the consumer. It is interesting watching what has gone on because in Q1, if you look at January and half of February, and let us call it in Performance Chemicals, great order pattern, everybody was excited. Then all of a sudden, all the tariff talk hit and things slowed down. Ian CleminsonEVP and CFO at Innospec00:15:06We are starting to see pickup again, starting in Q2. It is going to be interesting to see how this plays out over the next 90 days and see where everything falls out with all the tariff conversations. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:15:21All right. That's very helpful. I wanted to dig in on the Performance Chemicals business. You just mentioned that you've seen kind of a strength to start the year and then a sharp weakening and now some improvement. We tend to think of that as being a pretty resilient business, selling into mostly personal care and some household applications. I'm curious, do you think what you're seeing there in those trends is related more to what your customers are doing to manage inventory levels and production? Is this more of an end consumer trade down or weakening? I guess the second piece of that is just your commentary around the margin trajectory there. Is that really just having to do with volume leverage? Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:16:18Are there changes in mix or price cost pressures or other factors that are playing into your more cautious view on the margin in Performance Chemicals? Ian CleminsonEVP and CFO at Innospec00:16:30Yeah, I'll start with the first part of your question. I think it was a little bit of both. I think, for instance, when COVID hit and you saw a lot of our customers stuck with inventory, didn't know what the consumer was going to do, there was complete panic in the marketplace. This is not like COVID from that standpoint. This was a reset button where the customer said, our customers said, what's the consumer going to do? Right? And until we know that, we're just going to pull back a little bit. I think that's starting to filter its way out. I do think that this agreement with the U.K. is a start of other agreements to come, I think, especially in Europe. I think that will be a net positive over the short and long term. Ian CleminsonEVP and CFO at Innospec00:17:20We're starting to see the consumer settle down a little bit. There's still the big concern around inflationary pricing. There's still big concerns about a global recession. We haven't seen the panic button, and we are starting to see that increase, which is a positive. Our customers who are directly related to the consumer are starting to buy again. That's a positive. We won't really be able to kind of give you more guidance than that until we see how these next couple of months go due to the volatility in the marketplace. We'll just sit tight and kind of give you guys as much feedback as we can. In regards to pricing, it was mixed. I also think, and there's a plan going on internally in all of our businesses on margin improvement and cost improvement. Ian CleminsonEVP and CFO at Innospec00:18:10We're doing that across all three of our business units. A lot of what happened is you had good volume, but you didn't have the best mix. I think that that's going to work itself out over time as well. I do think we're sitting in a good position. I think there is just a wait-and-see mode to see kind of what happens over the next 90 days. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:18:33All right. You specifically mentioned some cost actions that you're taking within the Oilfield Services business. I was just curious if you could give some additional detail on what you're doing there. Patrick WilliamsPresident and CEO at Innospec00:18:49Yeah, I mean, it's overall. It's consolidation of assets. It's personnel. It's efficiencies. It's raw material costing. There's a lot of things that we're doing that we've been working on. It's ongoing, but we should start seeing those benefits at least in Q3 and Q4. These are cost initiatives that have been going on for quite some time, and we have really put the pressure on to get these moving. It's an interesting dynamic in the market right now with crude prices where they are and what's going on globally with OPEC increasing their production. The good thing about that business is it's well-diversified now. I think if we get some things right in the U.S., there's a lot of upside. Patrick WilliamsPresident and CEO at Innospec00:19:38If our Latin America customer comes back, which we do think we still think they will at some time, that's going to be a net positive overall when that happens. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:19:51All right. The last question for me is just if you can walk through maybe how we should be thinking about earnings cadence for the rest of the year. I'm curious, when I look at overall operating income, is Q2 expected to be sequentially lower and then maybe we get back to sequential improvement for the rest of the year? I know it's kind of a limited visibility environment, but any color that you could provide on the outlook would be very helpful. Thanks. Ian CleminsonEVP and CFO at Innospec00:20:28Mike, let me take that one. I'll go business by business because it's probably a little bit easier. We think Fuel Specialties will be right on target for the full year. We don't think it'll be far off the expectations that you've set and the other analysts have set for the full year. Obviously, the second quarter and the third quarter do tend to dip down a little bit. That's seasonally driven. We don't see any impacts from tariffs, and we don't see any economic impacts blowing that business offline. I think in the second quarter in fuels, you'll see the revenues come off a little bit, and you'll see the operating income come down a little bit. That is all part of the seasonality. I think the way you've modeled it, Mike, is the way we see it for the second quarter. Ian CleminsonEVP and CFO at Innospec00:21:19I think in Performance Chemicals, I think what we'll probably see is a second quarter very similar to the first quarter in terms of sales, gross margins, and operating income. I think for the rest of the year, that's the sort of level that we expect the business will continue to operate at, absent any real fundamental change in the backdrop. I think certainly for the second and third quarter, that's what we expect. If things shake out more positively, we'd expect that business to improve its margins and improve its operating income. For now, I think Q1 is reflective of what we'll see in the second quarter. For Oilfield, as we've talked about on the call already, there's a lot of initiatives going on, not just to cut costs and not just to reorganize internally, but to also grow that business. Ian CleminsonEVP and CFO at Innospec00:22:12We have some really strong areas of growth in the Middle East and DRA and other parts of the business that we want to continue to push hard. We do need to right-size ourselves in other places. Our expectation for the second quarter is something similar, if not slightly better than the first quarter. The third quarter, again, should be sequentially improved. Hopefully, the fourth quarter will improve again. From here on in, we expect to see some very slight improvement in our oil field business. We expect Performance Chemicals to be pretty similar to Q1, and we expect our fuel business to be absolutely on target for the full year. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:22:56All right. Sounds good. Thank you very much. Operator00:22:59Thank you. Patrick WilliamsPresident and CEO at Innospec00:22:59Thank you very much, Mike. Operator00:23:01Now we're going to take our next question. The question comes from the line of Jon Tanwanteng from CJS Securities. Your line is open. Please ask your question. Jon TanwantengManaging Director at CJS Securities00:23:13Hi. Thank you for taking my questions. I was wondering if you could dig a little bit deeper into your expectation for Fuel Specialties being relatively unaffected, just because I've seen a couple of forecasts that are suggesting that fuel volumes and pricing are going to decline as we see these ships come in with half loads and trucking to follow that. Just any thoughts on how those two reconcile, if you don't believe them, or if it's just too small of a volume to matter in a global context? Any help there would be appreciated. Ian CleminsonEVP and CFO at Innospec00:23:44Yeah, Jon, I think in the global context, if you look historically at Fuel Specialties, whether it's a recessionary environment, inflationary environment, it's always been historically a very stable business, not only from a cash flow, but from a revenue and operating income standpoint. We don't see there's puts and takes in that business that we'll maybe see some negative on fuels, but a positive on the other side. We just don't see it. Our order patterns don't show it. Our customer communication is telling us otherwise. Because of the resiliency of that business, as Ian alluded to, we see a strong year for that business moving forward. Jon TanwantengManaging Director at CJS Securities00:24:31Okay. Great. Thank you. Ian, if you could more specifically quantify what's moving between Europe and the U.S., either one way or the other, just to help us understand the exposures on a tariff perspective. If you have a number for China, that would be helpful too. Ian CleminsonEVP and CFO at Innospec00:24:49Yeah. I'm not going to give you specific numbers, Jon, but what I can say is it's pretty immaterial across the group. Very, very low on China both ways. We sell very little into China, and we import very little raw materials directly into the U.S. We do not see a problem there. Trade between the U.S. and Europe and Europe and the U.S., a lot of that can be intercompany. A lot of it can be services, which so far are exempt from the tariffs. That was where we will see some impacts. This is where we've got the most flexibility, where we can move our manufacturing assets, and we can flex what we want to do, and we can flex the supply chain somewhat. It's not something that we're ignoring. It's not something that we're panicking about. We have options. Ian CleminsonEVP and CFO at Innospec00:25:45We're not talking hundreds of millions of dollars here, Jon. We're talking very manageable amounts that we feel that we can navigate our way through. Jon TanwantengManaging Director at CJS Securities00:25:56Okay. Great. Thank you. Lastly, you mentioned that you saw a little bit of a pickup in the trends in Performance Chemicals in this quarter, I guess, as negotiations have gone on and people have maybe assumed the tariffs will not be as bad. I am wondering if you have seen the same pickup in Oilfield Services or the expectation for, I guess, sequential improvement is more of your internal efforts than maybe overall demand. Ian CleminsonEVP and CFO at Innospec00:26:18Yeah. I think overall in Oilfield Services, a lot of it's going to be internal efforts. As we alluded to in our previous conversations, we're hoping to see that Latin America business come back. We've expanded more into the Middle East. We're expanding our DRA capacity, which is going to be beneficial to that business. We're streamlining things in the U.S., which needs to be done. A lot of the pullback on crude is, yes, you had OPEC add some barrels to the market. More importantly, as you said earlier, Jon, is that people were discussing, is there going to be a slowdown? Is the consumer going to slow down driving? Things of that nature. The fear is starting to subside. I do think that you're going to see some stabilization. Ian CleminsonEVP and CFO at Innospec00:27:08I think if you look at crude over the last couple of days, it's gone up. I think as long as we're not seeing a complete crash in crude prices, Oilfield Services is going to be okay. Jon TanwantengManaging Director at CJS Securities00:27:21Okay. Great. Thank you. Operator00:27:23Thank you. Ian CleminsonEVP and CFO at Innospec00:27:24Thank you. Operator00:27:26Dear participants, as a reminder, if you wish to ask a question, please press star one one on your telephone keypad. We are going to take our next question. It comes from the line of David Silver from C.L. King & Associates. Your line is open. Please ask a question. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:27:45Yeah. Hi. Good morning. Thank you. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:27:48Good morning, David. Ian CleminsonEVP and CFO at Innospec00:27:49Morning, David. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:27:49Hey. Good morning. Yes. Good morning. I have a question, I guess, more focused on your R&D efforts and collaborations in particular with key customers. Kind of projects that are due to develop over the next year or so, let's just say, year or more. With all the tariff uncertainty that you've highlighted, I'm trying to draw maybe a contrast between how your customers are reacting near-term versus maybe projects and collaborations with a longer timetable, let's say, to play out. I think your R&D spend this quarter was an all-time high. I was just wondering if you could maybe give us a sense of how your collaboration partners on product development and just longer-term R&D are reacting in the current environment. In other words, is there any pause? Are they rethinking maybe the supply chain or the logistics shifting timetables? David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:29:07Just what would you say has been the feedback from your major customers that you're working on this kind of somewhat over-the-horizon projects? Thank you. Ian CleminsonEVP and CFO at Innospec00:29:22Yeah, David. We really haven't seen any change in the mindset across all three of our business units. If you look at our R&D that we do joint collaboration with, there are specified projects for specified outcomes or performance. You have our disruptive technology that looks at what's over the next 5 years-10 years, what's that horizon look like, what's driving the regulatory environment, what type of performance characteristics we look for, what's completely game-changing. They are really two different sectors. When you look at our actual customers that we do joint collaboration projects across all three business units, there hasn't been a change in mindset. As I said earlier, whether it's regulatory-driven or performance-driven, there hasn't been a mindset change whatsoever. That has not slowed down. Ian CleminsonEVP and CFO at Innospec00:30:15I think in some instances, quite frankly, it's probably picked up because they want to see something new to introduce to the market. It's actually a positive at some points in these times when you do see a little bit of increase in R&D because people are starting to look at things differently, which is typically beneficial to us. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:30:38Okay. Great. Thank you for that. My next question would be just maybe to drill down a tiny bit on the Fuel Specialties quarter. Revenue was down. You said price mix was down a bit, but margins and operating income was up double digits. I'm just wondering if you could highlight maybe within your portfolio there or your different product lines where you think the greatest improvement was experienced this quarter. I'm kind of wondering, is Jet fuel now, has it been restored to its traditional share of your overall Fuel Specialties business? Also wondering, with another company I follow, they're noting kind of a decent adoption of the GDi engines in certain regions. I'm just wondering if that is playing into some of the improved results on the margin line this quarter. Thank you. Patrick WilliamsPresident and CEO at Innospec00:31:49Sure. I'll let Ian take the front portion. Ian, I'll add to your comments. Ian CleminsonEVP and CFO at Innospec00:31:55Sure. So yeah, we're really pleased with the Fuel Specialties business this quarter, David. And what we've seen is really good margin performance across all three regions in EMEA, the Americas, and Asia-Pacific. So it's not centered on any one region. The sales mix was certainly more favorable to us this quarter year over year. But what we're seeing is good momentum across all product lines. And we're really pleased with that. There's some new business coming through. Patrick talked a little bit earlier about how we'll win some business and we'll lose some. We're starting to see some GDi business coming through now, which is nice-sized and a really good start for us. So we've got a lot of expectations for this business to maintain the momentum through the remainder of the year. And the team have done a great job, and they're well-positioned to execute against that. Patrick WilliamsPresident and CEO at Innospec00:32:52No further comments, David, from me. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:32:56That's okay. Very good. One other question would be kind of on the capital deployment, I guess, side of things. You did get a $50 million authorization for share repurchase. You did mention the $3.3 million of buybacks this quarter. I think looking at the cash flow statement, there was even a little bit more activity than that. Just big picture 2025 as a whole, is that buyback authorization or flexibility, is that likely to be used just to offset options-related issuance? Or might you say you're thinking of being a little more opportunistic in the current environment? Thank you. Ian CleminsonEVP and CFO at Innospec00:33:53Yeah. Good question. I think it's the second part of your answer. We're looking to be a little more opportunistic in this market. We've been continuing to buy back. We'll continue to buy back where we're sitting today. I think it's healthy for us. When you talk about overall capital structure, we have the cash in place to do multiple things, continue to grow our business organically, to look at M&A, to increase our dividend, which we just did, and to continue our buybacks. We're in a good position from a balance sheet standpoint. I think that we're well-balanced in what we're trying to accomplish. We just want to make sure that we've got some firepower for M&A if the right one comes along. Ian CleminsonEVP and CFO at Innospec00:34:43There's still a little bit—and I'm sure the question's going to come—there's still a little bit of a disconnect between what the seller thinks is value versus what the buyer is willing to pay. We are seeing there is deal slowdown, but there are deals on the market that could potentially be a really good pickup for us if we can get it at the right price. Our balance sheet really gives us the flexibility to do all of those. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:35:09Got it. Okay. Great. That's it for me. Thank you very much. Ian CleminsonEVP and CFO at Innospec00:35:14Thanks, David. Operator00:35:15Thank you. Ian CleminsonEVP and CFO at Innospec00:35:15Thanks, David. Operator00:35:20The speakers are on for the questions for today. I would now like to hand the conference over to Patrick Williams for any closing remarks. Patrick WilliamsPresident and CEO at Innospec00:35:28Thank you all for joining us today. Thank you to all our shareholders, customers, and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our second quarter 2025 results in August. Have a great day. Operator00:35:48This concludes today's conference call. Thank you for participating. You may now disconnect. Have a nice day.Read moreParticipantsExecutivesPatrick WilliamsPresident and CEOIan CleminsonEVP and CFODavid JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate SecretaryAnalystsMike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research PartnersDavid SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & AssociatesJon TanwantengManaging Director at CJS SecuritiesPowered by Earnings DocumentsSlide DeckPress Release(8-K)Quarterly report(10-Q) Innospec Earnings HeadlinesInnospec (IOSP)September 29 at 9:08 AM | es.investing.comInnospec (NASDAQ:IOSP) Sets New 1-Year High - What's Next?September 29 at 3:03 AM | americanbankingnews.comA Little Known Explorer Sits Near Major Gold DepositsBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourmile, Goldrush, and Cortez Hills, a region that could hold as much as 60 million ounces of gold. Bordering Fourmile and less than a mile from Goldrush sits a little-known explorer now moving from historical data toward active exploration, setting targets and preparing for a maiden drilling program. With gold trading near record highs, this could be a pivotal stage for an overlooked name in the district.September 30 at 1:00 AM | Wall Street Logic (Ad)Innospec (NASDAQ:IOSP) Stock Rating Cut to "Buy" at Wall Street ZenSeptember 26, 2026 | americanbankingnews.comInnospec股價創52週新高,報97.2美元September 23, 2026 | hk.investing.comInnospec (IOSP) Q2 2026 Earnings Call TranscriptAugust 14, 2026 | fool.comSee More Innospec Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Innospec? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Innospec and other key companies, straight to your email. Email Address About InnospecInnospec (NASDAQ:IOSP) (NASDAQ: IOSP) is a global specialty chemicals company that develops, manufactures and supplies products used in the energy, transportation, personal care, household, agriculture and industrial markets. Its offerings are designed to improve product performance, support manufacturing processes and address specialized customer requirements. The company operates through businesses focused on fuel specialties, performance chemicals and oilfield services. Its products include fuel additives and performance-enhancing chemicals for gasoline, diesel and other fuels, as well as ingredients and formulations used in personal care, home care, crop protection, construction, mining and other industrial applications. Innospec also provides chemicals and services used in oil and gas exploration, production and well treatment. Innospec serves customers internationally through manufacturing, research and development, technical service and commercial operations in multiple regions. The company’s roots extend to the development and supply of fuel additives and related specialty chemicals, and it has expanded its portfolio over time to serve a broader range of industrial and consumer markets.View Innospec ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBernstein Downgrades 3 Cybersecurity Stocks: How Concerned Should Investors Be?Brewing Trouble? Starbucks Spills the Beans on 250 Store ClosuresMarketBeat Week in Review – 09/21 - 09/25Analyst Rating Boosts May Signal More Upside for These 3 Stocks3 Stocks Under the Microscope After Large Insider Sales3 Healthcare Stocks Showing Why the Sector Still Has Momentum Upcoming Earnings NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PresentationSkip to Participants Operator00:00:00Thank you for standing by. Welcome to Innospec's first quarter 2025 earnings release and conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be the question-and-answer session. To ask a question during the session, you need to press star one one* on your telephone keypad. You will then hear an automatic message advising your hand is raised. To withdraw a question, please press star one one* again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead. David JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate Secretary at Innospec00:00:37Thank you. Welcome to Innospec's first quarter earnings call. The earnings release for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risk and uncertainties that could cause actual results to differ materially from anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's 10-K, 10-Qs, and other filings with the SEC. Please see the SEC site and Innospec site for these and related documents. In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for or superior to those prepared in accordance with GAAP. David JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate Secretary at Innospec00:01:29They are included as additional items to aid investor understanding of the company's performance in addition to the impact that these items and events had on financial results. With me today from Innospec are Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer. With that, turn it over to you, Patrick. Patrick WilliamsPresident and CEO at Innospec00:01:47Thank you, David, and welcome everyone to Innospec's first quarter 2025 conference call. This was a good quarter for Innospec with overall results in line with our expectations. Against an increasingly volatile economic backdrop, our balanced portfolio benefited from strong growth in Fuel Specialties, which offset lower results in Performance Chemicals and Oilfield Services. Performance Chemicals began the quarter with good momentum, similar to other companies' activity moderated due to April 2 tariff announcements. While the majority of our products go into consumer staples, we believe that customers will remain conservative and manage inventory levels closely in the short term while uncertainty surrounding trade policy remains. While the second quarter has started broadly similar to the first, market conditions are extremely volatile. We currently expect these conditions to be a headwind against our stated 2025 target for sequential improvement in operating income. Patrick WilliamsPresident and CEO at Innospec00:02:50Despite these near-term challenges, our pipeline continues to develop in all end markets, and we do not see any change in our customers' long-term drive towards technologies which deliver superior performance and value. Fuel Specialties had an excellent quarter. Operating income grew by double digits and margins expanded. The team continued to make progress on margin improvement with all regions contributing to the strong performance. While there is significant uncertainty in the current market, global fuel demand has historically been relatively steady through economic cycles. In addition, our Fuel Specialties business has been a consistent high-margin, strong cash generator. Against this backdrop, we remained focused on delivering full-year operating income growth and margin improvement. Oilfield Services' operating income and margins were below our target and expectations. Operating income declined on a sequential basis on lower-than-expected activity. Patrick WilliamsPresident and CEO at Innospec00:03:54As expected, there were no sales in Latin America, and any potential recovery is likely delayed due to the indirect impact of ongoing trade policy negotiations. These declines were partially offset by continued growth and strong performance in our Middle East and our DRA business. We remain on track to bring our previously announced expansion for our market-leading proprietary DRA technology online in the fourth quarter. In addition to our top-line initiatives, we have begun a series of actions to align our U.S. cost structure with the market. We expect these initiatives to drive sequential operating income and margin improvement in the coming quarters and leave us well-positioned for profitable growth. Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. I will return with some concluding comments. After that, Ian and I will take your questions. Ian. Ian CleminsonEVP and CFO at Innospec00:04:53Thanks, Patrick. During slide seven in the presentation, the company's total revenues for the first quarter were $440.8 million, a 12% decrease from $500.2 million a year ago. Overall gross margin decreased by 2.7 percentage points from last year to 28.4%. Adjusted EBITDA for the quarter was $54 million compared to $64 million last year, and net income for the quarter was $32.8 million compared to $41.4 million a year ago. Our GAAP earnings per share were $1.31, including special items, the net effect of which decreased our first quarter earnings by $0.11 per share. A year ago, we reported GAAP earnings per share of $1.65, which included the negative impact from special items of $0.10 per share. Excluding special items in both years, our Adjusted EPS for the quarter was $1.42 compared to $1.75 a year ago. Ian CleminsonEVP and CFO at Innospec00:06:05Turning to slide eight, revenues in Performance Chemicals for the first quarter were $168.4 million, up 5% from last year's $160.8 million. Volume growth of 5% and a positive price mix of 3% were offset by a negative currency impact of 3%. Gross margins of 21% decreased 2.4 percentage points compared to 23.4% in the same quarter in 2024 due to a weaker sales mix and lower sales pricing. Operating income of $19.8 million decreased 6% on $21.1 million last year. Moving on to slide nine, revenues in Fuel Specialties for the first quarter were $170.3 million, down 4% from the $176.9 million reported a year ago, with a 2% adverse price mix and a negative currency impact of 2%. Fuel Specialties' gross margins of 35.7% were 1.4 percentage points above the same quarter last year, benefiting from a stronger sales mix and stable pricing. Ian CleminsonEVP and CFO at Innospec00:07:24Operating income of $36.9 million was up 10% from $33.4 million a year ago. Moving on to slide ten, revenues in Oilfield Services for the quarter were $102.1 million, down 37% from $162.5 million in the first quarter last year, driven mostly by a lack of Latin American business. Gross margins of 28.4% decreased 6.9 percentage points from last year's 35.3% on a weaker sales mix. Operating income of $4.1 million decreased 76% from $16.9 million one year ago. It is now over a year since we made sales to our major Latin American customer. From Q2 onwards, our quarterly results will be directly comparable and not show the sharp decreases we have seen year over year from this one piece of business. Turning to slide eleven, corporate costs for the quarter were $17.7 million compared with $20.2 million a year ago, driven by lower personnel-related costs. Ian CleminsonEVP and CFO at Innospec00:08:37The effective tax rate for the quarter was 26.1% compared to 25.1% a year ago. Moving on to slide twelve, cash from operating activities was $28.3 million before capital expenditures of $15.5 million. For the first quarter, we bought back 34,100 shares at a cost of $3.3 million. As of March 31st, Innospec had $299.8 million in cash and cash equivalents and no debt. I'll turn it back over to Patrick for some final comments. Patrick WilliamsPresident and CEO at Innospec00:09:17Thank you, Ian. With our diversified global supply chain and manufacturing locations, we believe that we are well-positioned to manage the direct impacts of the global tariffs. Despite any near-term volatility, we remain focused on our continued commitment to security of supply, innovation, and world-class customer service. We will continue to implement improvements across all our businesses that will position us for growth and margin expansion as market conditions recover. Our strong debt-free balance sheet allows for significant flexibility in the current environment to pursue further M&A, dividend growth, organic investment, and buybacks. Cash generation was again positive this quarter, and our net cash position increased to almost $300 million after purchasing 34,100 shares at a cost of $3.3 million. In addition, this quarter, our board approved a further 10% increase in our semiannual dividend to $0.84 per share, continuing our record of returning value to shareholders. Patrick WilliamsPresident and CEO at Innospec00:10:25Now I will turn the call over to the operator, and Ian and I will take your questions. Operator00:10:30Thank you, dear participants. As a reminder, if you wish to ask a question, please press star one one on your telephone keypad and wait for your name to be announced. To withdraw a question, please press star one one again. Please then bow or compile the Q&A or study. This will take a few moments. Now we are going to take up our first question. It comes from the line of Mike Harrison from Seaport Research Partners. Your line is open. Please ask your question. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:10:59Hi, good morning. Ian CleminsonEVP and CFO at Innospec00:11:01Morning, Mike. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:11:03Morning, Mike. I was hoping that you could give us maybe a little bit more detail on how you guys are looking at the direct impact of tariffs. Any color that you can provide on what tariffs could mean to your input costs? If you could also give us any detail on portions of your business where you're maybe exporting out of the U.S. and could see some of your products affected by tariffs or bringing product into the U.S., I guess. Ian CleminsonEVP and CFO at Innospec00:11:41Yeah, Mike, I'll let Ian start with that question. I'm sure I have some additional information to add. Patrick WilliamsPresident and CEO at Innospec00:11:48Sure. Mike, like many other companies, we're monitoring the situation. It changes daily, so it's not an easy backdrop to plan against. Our supply chains are really well-positioned to source and manufacture across the different regions. We have various optionality there which we can implement. We're monitoring tariffs, and a lot of that is really an extension of the supply chain and logistics problems that we've seen over the last number of years, including during the pandemic. As more details emerge, we'll position ourselves accordingly. What we're not going to do is make knee-jerk reactions, change manufacturing, change supply chain until we're absolutely certain of the background position. In terms of the general impacts, they're not that high. Our trade with China, both in terms of raw materials and finished products, is pretty low. We do have a lot of trade from Europe into the U.S. Patrick WilliamsPresident and CEO at Innospec00:12:53from the U.S. into Europe. Each of the businesses is slightly differently impacted. We believe that in Performance Chemicals, the main impact will not be economic in terms of the impact of tariffs. It will actually be on the consumer and the customer caution that we have seen in the first quarter. We think that will be the main headwind. That does not change our focus on the R&D and the investment in the technologies that we have. We do not think that changes any direction from our customers. I think in Fuel Specialties, again, that is a business that is regionally based. I think we can handle all the different dynamics there. As we have moved through different economic cycles with that business, it tends to be a fairly stable business. We do not expect there to be any financial impacts or any economic headwinds in that business. Patrick WilliamsPresident and CEO at Innospec00:13:48I think in Oilfield Services, our main concern is with Mexico and the difficult negotiations that are going on there. That's likely to delay any resumption of the Mexican business, which we lost just over a year ago. There are a lot of moving parts across all our business, but most of it we think we can manage. As long as we've got a firm and solid backdrop, we'll deal with what's in front of us. Ian CleminsonEVP and CFO at Innospec00:14:15Yeah, I think Mike and Ian covered it very, very well. I think the key here is that you do not panic in markets like this. It will work itself out. As Ian alluded to, we do not have a lot of imports or exports going from China and/or India. I think that the positive is, too, is we have flexible assets. If and when we need to turn those assets a different direction, we can do that. We are in a strong position there. I think another thing, a little bit of color to that, too, is Ian alluded to the consumer. It is interesting watching what has gone on because in Q1, if you look at January and half of February, and let us call it in Performance Chemicals, great order pattern, everybody was excited. Then all of a sudden, all the tariff talk hit and things slowed down. Ian CleminsonEVP and CFO at Innospec00:15:06We are starting to see pickup again, starting in Q2. It is going to be interesting to see how this plays out over the next 90 days and see where everything falls out with all the tariff conversations. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:15:21All right. That's very helpful. I wanted to dig in on the Performance Chemicals business. You just mentioned that you've seen kind of a strength to start the year and then a sharp weakening and now some improvement. We tend to think of that as being a pretty resilient business, selling into mostly personal care and some household applications. I'm curious, do you think what you're seeing there in those trends is related more to what your customers are doing to manage inventory levels and production? Is this more of an end consumer trade down or weakening? I guess the second piece of that is just your commentary around the margin trajectory there. Is that really just having to do with volume leverage? Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:16:18Are there changes in mix or price cost pressures or other factors that are playing into your more cautious view on the margin in Performance Chemicals? Ian CleminsonEVP and CFO at Innospec00:16:30Yeah, I'll start with the first part of your question. I think it was a little bit of both. I think, for instance, when COVID hit and you saw a lot of our customers stuck with inventory, didn't know what the consumer was going to do, there was complete panic in the marketplace. This is not like COVID from that standpoint. This was a reset button where the customer said, our customers said, what's the consumer going to do? Right? And until we know that, we're just going to pull back a little bit. I think that's starting to filter its way out. I do think that this agreement with the U.K. is a start of other agreements to come, I think, especially in Europe. I think that will be a net positive over the short and long term. Ian CleminsonEVP and CFO at Innospec00:17:20We're starting to see the consumer settle down a little bit. There's still the big concern around inflationary pricing. There's still big concerns about a global recession. We haven't seen the panic button, and we are starting to see that increase, which is a positive. Our customers who are directly related to the consumer are starting to buy again. That's a positive. We won't really be able to kind of give you more guidance than that until we see how these next couple of months go due to the volatility in the marketplace. We'll just sit tight and kind of give you guys as much feedback as we can. In regards to pricing, it was mixed. I also think, and there's a plan going on internally in all of our businesses on margin improvement and cost improvement. Ian CleminsonEVP and CFO at Innospec00:18:10We're doing that across all three of our business units. A lot of what happened is you had good volume, but you didn't have the best mix. I think that that's going to work itself out over time as well. I do think we're sitting in a good position. I think there is just a wait-and-see mode to see kind of what happens over the next 90 days. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:18:33All right. You specifically mentioned some cost actions that you're taking within the Oilfield Services business. I was just curious if you could give some additional detail on what you're doing there. Patrick WilliamsPresident and CEO at Innospec00:18:49Yeah, I mean, it's overall. It's consolidation of assets. It's personnel. It's efficiencies. It's raw material costing. There's a lot of things that we're doing that we've been working on. It's ongoing, but we should start seeing those benefits at least in Q3 and Q4. These are cost initiatives that have been going on for quite some time, and we have really put the pressure on to get these moving. It's an interesting dynamic in the market right now with crude prices where they are and what's going on globally with OPEC increasing their production. The good thing about that business is it's well-diversified now. I think if we get some things right in the U.S., there's a lot of upside. Patrick WilliamsPresident and CEO at Innospec00:19:38If our Latin America customer comes back, which we do think we still think they will at some time, that's going to be a net positive overall when that happens. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:19:51All right. The last question for me is just if you can walk through maybe how we should be thinking about earnings cadence for the rest of the year. I'm curious, when I look at overall operating income, is Q2 expected to be sequentially lower and then maybe we get back to sequential improvement for the rest of the year? I know it's kind of a limited visibility environment, but any color that you could provide on the outlook would be very helpful. Thanks. Ian CleminsonEVP and CFO at Innospec00:20:28Mike, let me take that one. I'll go business by business because it's probably a little bit easier. We think Fuel Specialties will be right on target for the full year. We don't think it'll be far off the expectations that you've set and the other analysts have set for the full year. Obviously, the second quarter and the third quarter do tend to dip down a little bit. That's seasonally driven. We don't see any impacts from tariffs, and we don't see any economic impacts blowing that business offline. I think in the second quarter in fuels, you'll see the revenues come off a little bit, and you'll see the operating income come down a little bit. That is all part of the seasonality. I think the way you've modeled it, Mike, is the way we see it for the second quarter. Ian CleminsonEVP and CFO at Innospec00:21:19I think in Performance Chemicals, I think what we'll probably see is a second quarter very similar to the first quarter in terms of sales, gross margins, and operating income. I think for the rest of the year, that's the sort of level that we expect the business will continue to operate at, absent any real fundamental change in the backdrop. I think certainly for the second and third quarter, that's what we expect. If things shake out more positively, we'd expect that business to improve its margins and improve its operating income. For now, I think Q1 is reflective of what we'll see in the second quarter. For Oilfield, as we've talked about on the call already, there's a lot of initiatives going on, not just to cut costs and not just to reorganize internally, but to also grow that business. Ian CleminsonEVP and CFO at Innospec00:22:12We have some really strong areas of growth in the Middle East and DRA and other parts of the business that we want to continue to push hard. We do need to right-size ourselves in other places. Our expectation for the second quarter is something similar, if not slightly better than the first quarter. The third quarter, again, should be sequentially improved. Hopefully, the fourth quarter will improve again. From here on in, we expect to see some very slight improvement in our oil field business. We expect Performance Chemicals to be pretty similar to Q1, and we expect our fuel business to be absolutely on target for the full year. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:22:56All right. Sounds good. Thank you very much. Operator00:22:59Thank you. Patrick WilliamsPresident and CEO at Innospec00:22:59Thank you very much, Mike. Operator00:23:01Now we're going to take our next question. The question comes from the line of Jon Tanwanteng from CJS Securities. Your line is open. Please ask your question. Jon TanwantengManaging Director at CJS Securities00:23:13Hi. Thank you for taking my questions. I was wondering if you could dig a little bit deeper into your expectation for Fuel Specialties being relatively unaffected, just because I've seen a couple of forecasts that are suggesting that fuel volumes and pricing are going to decline as we see these ships come in with half loads and trucking to follow that. Just any thoughts on how those two reconcile, if you don't believe them, or if it's just too small of a volume to matter in a global context? Any help there would be appreciated. Ian CleminsonEVP and CFO at Innospec00:23:44Yeah, Jon, I think in the global context, if you look historically at Fuel Specialties, whether it's a recessionary environment, inflationary environment, it's always been historically a very stable business, not only from a cash flow, but from a revenue and operating income standpoint. We don't see there's puts and takes in that business that we'll maybe see some negative on fuels, but a positive on the other side. We just don't see it. Our order patterns don't show it. Our customer communication is telling us otherwise. Because of the resiliency of that business, as Ian alluded to, we see a strong year for that business moving forward. Jon TanwantengManaging Director at CJS Securities00:24:31Okay. Great. Thank you. Ian, if you could more specifically quantify what's moving between Europe and the U.S., either one way or the other, just to help us understand the exposures on a tariff perspective. If you have a number for China, that would be helpful too. Ian CleminsonEVP and CFO at Innospec00:24:49Yeah. I'm not going to give you specific numbers, Jon, but what I can say is it's pretty immaterial across the group. Very, very low on China both ways. We sell very little into China, and we import very little raw materials directly into the U.S. We do not see a problem there. Trade between the U.S. and Europe and Europe and the U.S., a lot of that can be intercompany. A lot of it can be services, which so far are exempt from the tariffs. That was where we will see some impacts. This is where we've got the most flexibility, where we can move our manufacturing assets, and we can flex what we want to do, and we can flex the supply chain somewhat. It's not something that we're ignoring. It's not something that we're panicking about. We have options. Ian CleminsonEVP and CFO at Innospec00:25:45We're not talking hundreds of millions of dollars here, Jon. We're talking very manageable amounts that we feel that we can navigate our way through. Jon TanwantengManaging Director at CJS Securities00:25:56Okay. Great. Thank you. Lastly, you mentioned that you saw a little bit of a pickup in the trends in Performance Chemicals in this quarter, I guess, as negotiations have gone on and people have maybe assumed the tariffs will not be as bad. I am wondering if you have seen the same pickup in Oilfield Services or the expectation for, I guess, sequential improvement is more of your internal efforts than maybe overall demand. Ian CleminsonEVP and CFO at Innospec00:26:18Yeah. I think overall in Oilfield Services, a lot of it's going to be internal efforts. As we alluded to in our previous conversations, we're hoping to see that Latin America business come back. We've expanded more into the Middle East. We're expanding our DRA capacity, which is going to be beneficial to that business. We're streamlining things in the U.S., which needs to be done. A lot of the pullback on crude is, yes, you had OPEC add some barrels to the market. More importantly, as you said earlier, Jon, is that people were discussing, is there going to be a slowdown? Is the consumer going to slow down driving? Things of that nature. The fear is starting to subside. I do think that you're going to see some stabilization. Ian CleminsonEVP and CFO at Innospec00:27:08I think if you look at crude over the last couple of days, it's gone up. I think as long as we're not seeing a complete crash in crude prices, Oilfield Services is going to be okay. Jon TanwantengManaging Director at CJS Securities00:27:21Okay. Great. Thank you. Operator00:27:23Thank you. Ian CleminsonEVP and CFO at Innospec00:27:24Thank you. Operator00:27:26Dear participants, as a reminder, if you wish to ask a question, please press star one one on your telephone keypad. We are going to take our next question. It comes from the line of David Silver from C.L. King & Associates. Your line is open. Please ask a question. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:27:45Yeah. Hi. Good morning. Thank you. Mike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research Partners00:27:48Good morning, David. Ian CleminsonEVP and CFO at Innospec00:27:49Morning, David. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:27:49Hey. Good morning. Yes. Good morning. I have a question, I guess, more focused on your R&D efforts and collaborations in particular with key customers. Kind of projects that are due to develop over the next year or so, let's just say, year or more. With all the tariff uncertainty that you've highlighted, I'm trying to draw maybe a contrast between how your customers are reacting near-term versus maybe projects and collaborations with a longer timetable, let's say, to play out. I think your R&D spend this quarter was an all-time high. I was just wondering if you could maybe give us a sense of how your collaboration partners on product development and just longer-term R&D are reacting in the current environment. In other words, is there any pause? Are they rethinking maybe the supply chain or the logistics shifting timetables? David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:29:07Just what would you say has been the feedback from your major customers that you're working on this kind of somewhat over-the-horizon projects? Thank you. Ian CleminsonEVP and CFO at Innospec00:29:22Yeah, David. We really haven't seen any change in the mindset across all three of our business units. If you look at our R&D that we do joint collaboration with, there are specified projects for specified outcomes or performance. You have our disruptive technology that looks at what's over the next 5 years-10 years, what's that horizon look like, what's driving the regulatory environment, what type of performance characteristics we look for, what's completely game-changing. They are really two different sectors. When you look at our actual customers that we do joint collaboration projects across all three business units, there hasn't been a change in mindset. As I said earlier, whether it's regulatory-driven or performance-driven, there hasn't been a mindset change whatsoever. That has not slowed down. Ian CleminsonEVP and CFO at Innospec00:30:15I think in some instances, quite frankly, it's probably picked up because they want to see something new to introduce to the market. It's actually a positive at some points in these times when you do see a little bit of increase in R&D because people are starting to look at things differently, which is typically beneficial to us. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:30:38Okay. Great. Thank you for that. My next question would be just maybe to drill down a tiny bit on the Fuel Specialties quarter. Revenue was down. You said price mix was down a bit, but margins and operating income was up double digits. I'm just wondering if you could highlight maybe within your portfolio there or your different product lines where you think the greatest improvement was experienced this quarter. I'm kind of wondering, is Jet fuel now, has it been restored to its traditional share of your overall Fuel Specialties business? Also wondering, with another company I follow, they're noting kind of a decent adoption of the GDi engines in certain regions. I'm just wondering if that is playing into some of the improved results on the margin line this quarter. Thank you. Patrick WilliamsPresident and CEO at Innospec00:31:49Sure. I'll let Ian take the front portion. Ian, I'll add to your comments. Ian CleminsonEVP and CFO at Innospec00:31:55Sure. So yeah, we're really pleased with the Fuel Specialties business this quarter, David. And what we've seen is really good margin performance across all three regions in EMEA, the Americas, and Asia-Pacific. So it's not centered on any one region. The sales mix was certainly more favorable to us this quarter year over year. But what we're seeing is good momentum across all product lines. And we're really pleased with that. There's some new business coming through. Patrick talked a little bit earlier about how we'll win some business and we'll lose some. We're starting to see some GDi business coming through now, which is nice-sized and a really good start for us. So we've got a lot of expectations for this business to maintain the momentum through the remainder of the year. And the team have done a great job, and they're well-positioned to execute against that. Patrick WilliamsPresident and CEO at Innospec00:32:52No further comments, David, from me. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:32:56That's okay. Very good. One other question would be kind of on the capital deployment, I guess, side of things. You did get a $50 million authorization for share repurchase. You did mention the $3.3 million of buybacks this quarter. I think looking at the cash flow statement, there was even a little bit more activity than that. Just big picture 2025 as a whole, is that buyback authorization or flexibility, is that likely to be used just to offset options-related issuance? Or might you say you're thinking of being a little more opportunistic in the current environment? Thank you. Ian CleminsonEVP and CFO at Innospec00:33:53Yeah. Good question. I think it's the second part of your answer. We're looking to be a little more opportunistic in this market. We've been continuing to buy back. We'll continue to buy back where we're sitting today. I think it's healthy for us. When you talk about overall capital structure, we have the cash in place to do multiple things, continue to grow our business organically, to look at M&A, to increase our dividend, which we just did, and to continue our buybacks. We're in a good position from a balance sheet standpoint. I think that we're well-balanced in what we're trying to accomplish. We just want to make sure that we've got some firepower for M&A if the right one comes along. Ian CleminsonEVP and CFO at Innospec00:34:43There's still a little bit—and I'm sure the question's going to come—there's still a little bit of a disconnect between what the seller thinks is value versus what the buyer is willing to pay. We are seeing there is deal slowdown, but there are deals on the market that could potentially be a really good pickup for us if we can get it at the right price. Our balance sheet really gives us the flexibility to do all of those. David SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & Associates00:35:09Got it. Okay. Great. That's it for me. Thank you very much. Ian CleminsonEVP and CFO at Innospec00:35:14Thanks, David. Operator00:35:15Thank you. Ian CleminsonEVP and CFO at Innospec00:35:15Thanks, David. Operator00:35:20The speakers are on for the questions for today. I would now like to hand the conference over to Patrick Williams for any closing remarks. Patrick WilliamsPresident and CEO at Innospec00:35:28Thank you all for joining us today. Thank you to all our shareholders, customers, and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our second quarter 2025 results in August. Have a great day. Operator00:35:48This concludes today's conference call. Thank you for participating. You may now disconnect. Have a nice day.Read moreParticipantsExecutivesPatrick WilliamsPresident and CEOIan CleminsonEVP and CFODavid JonesSenior VP, General Counsel, Chief Compliance Officer, and Corporate SecretaryAnalystsMike HarrisonManaging Director and Senior Chemicals Analyst at Seaport Research PartnersDavid SilverManaging Director, Director of Equity Research, Senior Research Analyst at C.L. King & AssociatesJon TanwantengManaging Director at CJS SecuritiesPowered by